Publications by authors named "Kenneth C Hancock"

Claim this Profile
P
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.
Jonathan Oh, Minal Barve, Carolyn M Matthews, E Colin Koon, Thomas P Heffernan, Kenneth C Hancock

Gynecol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer.
Michael Friedlander, Kenneth C Hancock, Danny Rischin, Mark J Messing, Claude A Stringer

Gynecol Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer.
Alan N Gordon, Kenneth C Hancock, Carolyn M Matthews, Mark Messing, C A Stringer

Gynecol Oncol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis